LRH-1 Inhibitor-3
LRH-1 Inhibitor-3 is a small molecule that inhibits LRH-1 transcriptional activity, thereby decreasing the expression of target genes associated with cell growth and proliferation. LRH-1 Inhibitor-3 has shown potential in reducing cancer cell proliferation in human pancreatic, colon, and breast adenocarcinoma cell lines. LRH-1 Inhibitor-3 serves as a molecular probe for investigating the role of LRH-1 in various malignancies.
Product Specifications
CAS Number
1185410-60-9
UNSPSC
12352005
Hazard Statement
H315-H319-H335
Target
Orphan Nuclear Receptor; Orphan Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lrh-1-inhibitor-3.html
Smiles
CC(C1=CC(C2=CC=CC(C3=NN(C=C3)CCN4CCOCC4)=C2)=CC=C1)=O
Molecular Formula
C23H25N3O2
Molecular Weight
375.46
Precautions
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P362-P403+P233-P405-P501
References & Citations
[1]Structure-based discovery of antagonists of nuclear receptor LRH-1
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TGF-beta (1D11.16.8), CF647 conjugate, 0.1mg/mL
TRIM29 (TRIM29/1041), CF740 conjugate, 0.1mg/mL
TGF-beta (1D11.16.8), CF405S conjugate, 0.1mg/mL
GLUT-1 (Tumor Progression and Mesothelioma Marker) (GLUT1/2476), CF640R conjugate, 0.1mg/mL
CD10 (Membrane Metalloendopeptidase) (MME/1870), CF405S conjugate, 0.1mg/mL
